AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).1 EGPA is a rare, immune-mediated ...

The modern debate over ICSs in COPD has the catnip required to produce an academic catfight. It pits "statements" against ...

Kolkata: A young female constable on night duty at the doctors’ protest site outside Swasthya Bhavan fell ill in the early ...

One of the woman police personnel on duty, deployed near the barricade set up by Bidhannagar police to stop the junior ...

Researchers at the Radcliffe Department of Medicine have found patients treated with steroids are 2.6 times more likely to develop diabetes.

Researchers at the Radcliffe Department of Medicine have found patients treated with steroids are 2.6 times more likely to ...

Learn 5 expert tips from WHO on how to manage asthma effectively, control symptoms, and live a healthier life.

Patients being treated with steroids are more than twice as likely to develop diabetes, Oxford scientists have found.

While caution is being exercised everywhere about the dangers of the drug montelukast, its sale in India is unregulated, ...

GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and ...

Innovations in drug formulations, such as dry powder inhalers, metered-dose inhalers, and nebulizers, are playing a ...

Glucocorticoids (sometimes known as steroids) fight inflammation and are used to treat a wide range of inflammatory and autoimmune conditions, including asthma, rheumatoid arthritis, cancers and other ...